3.0 Credits - CME/CPE | Expires 3/15/2016
This activity is supported by an educational grant from Bristol-Myers Squibb and Gilead Sciences Inc.
Yekaterina Opsha, PharmD, BCPS
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Clinical Specialist, Cardiovascular Medicine
Saint Barnabas Medical Center
Livingston, New Jersey.
Gary M. Owens, MD
Gary Owens Associates
Ocean View, Delaware
Monica Shah, PharmD
Antimicrobial Stewardship Clinical Pharmacist
Monmouth Medical Center
Long Branch, New Jersey
Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF, FAASLD
Betty and Guy Beatty Center for Integrated Research Liver and Obesity Research Center
Department of Medicine Vice President for Research Inova Health System
Falls Church, Virginia
Hepatitis C virus (HCV) infection is a serious public health concern that affects an estimated 4 million individuals in the United States and 185 million worldwide and is linked to substantial clinical, economic, and societal burdens. Approximately 80% of patients with acute HCV infection progress to chronic infection; possible sequelae of chronic HCV infection include cirrhosis, hepatocellular carcinoma (HCC), and/or decompensated liver disease. The treatment paradigm and clinical outlook for HCV infection has shifted rapidly in the past few years and continues to evolve, with the introduction of recently approved agents and novel therapies, many drugs in the development pipeline, and the release of updated guidelines. Based on these factors, HCV has reinforced its position as a major contributor to rising healthcare costs in the United States and a focal point for specialty pharmacy and managed care. This supplement to The American Journal of Managed Care will provide an epidemiological and clinical overview of HCV, discuss current and emerging pharmacotherapeutic strategies for the disease, evaluate the burdens of HCV infection, and examine the new and evolving standards of care from a managed care perspective.
Upon completion of this activity, participants should be able to:
Managed care clinicians and administrators, including physicians, pharmacists, medical and formulary directors, and other managed care professionals involved in the care of patients with hepatitis C infection.
Release date: March 15, 2015 Expiration date: March 15, 2016
Estimated time to complete activity: 3.0 hours Type of activity: Knowledge
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Pharmacy Times Office of Continuing Professional Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this journal-based activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 3.0 contact hours (3.0 CEUs) under the ACPE universal activity number 0290-9999-15-020-H01-P. The activity is available for CE credit through March 15, 2016.
Important Instructions for Obtaining CPE Credit:
To receive a Statement of Credit, participants must complete the pretest, read the article in its entirety and complete the online evaluation and post-test with a score of 70% or better before the activity expires. After successful completion and submission of the online posttest and activity evaluation your credit will be uploaded to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net..
NOTE: All steps must be completed in order to receive credit. Please ensure your Pharmacy Times account is updated with your NABP e-profile number and your date of birth (MMDD format). Participation data will not be uploaded into CPE MonitorTM if you do not have your NABP e-profile number and date of birth entered into your profile on www.pharmacytimes.org.
For Physician credit (CME) only
For Pharmacy credit (CPE) only
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Required: Mac OS® X 10.4.11 (Tiger®) or newer
For questions about this Internet CPE activity, please contact: firstname.lastname@example.org.